Aldeyra Therapeutics
ALDX
#10236
Rank
C$72.7 M
Marketcap
C$1.20
Share price
16.39%
Change (1 day)
-82.78%
Change (1 year)

Earnings for Aldeyra Therapeutics (ALDX)

Earnings in 2026 (TTM): -C$30.14 Million

According to Aldeyra Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$45.81 Million, an increase over its 2024 earnings that were of -C$77.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aldeyra Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$30.14 Million-34.22%
2025 -C$45.81 Million-40.77%
2024 -C$77.33 Million52.03%
2023 -C$50.87 Million-41.21%
2022 -C$86.52 Million7.67%
2021 -C$80.36 Million55.1%
2020 -C$51.81 Million-41.29%
2019 -C$88.24 Million58.81%
2018 -C$55.57 Million74.32%
2017 -C$31.88 Million19.56%
2016 -C$26.66 Million55.21%
2015 -C$17.18 Million142.32%
2014 -C$7.09 Million-137.39%
2013 C$18.95 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
C$8.15 B-26,387.74%๐Ÿ‡บ๐Ÿ‡ธ USA